---
title: "CIREL study finds comparable overall survival between indication for irinotecan-TACE in colorectal liver metastases"
date: "2025-03-06T09:31:42.000Z"
publishedDate: "6 mars 2025"
summary: "Results from CIREL—the largest, pan-European, prospective study of irinotecan-eluting transarterial chemoembolization (TACE) for colorectal liver metastases (CRLMs), show a comparably long median overall survival (OS) when used as salvage therapy and “promising” hepatic progression-free survival (HPFS) when used with systemic therapy or thermal ablation as a post-inductive or consolidation therapy. The study, published in European [&#8230;] The post CIREL study finds comparable overall survival between indication for irinotecan-TACE in colorectal liver metastases appeared first on Interventional News ."
importance: ""
sourceUrl: "https://interventionalnews.com/cirel-study-finds-comparable-overall-survival-between-indication-for-irinotecan-tace-in-colorectal-liver-metastases/"
tags: ["France", "Actualité", "Interventional News — Latest"]
permalink: "/papers/2025-03-06-cirel-study-finds-comparable-overall-survival-between-indication-for-irinotecan-tace-in-colorectal-liver-metastases"
imageUrl: "http://interventionalnews.com/wp-content/uploads/sites/13/2025/03/national-cancer-institute-SP2C8o2EZBw-unsplash-scaled.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://interventionalnews.com/cirel-study-finds-comparable-overall-survival-between-indication-for-irinotecan-tace-in-colorectal-liver-metastases/"
---

![CIREL study finds comparable overall survival between indication for irinotecan-TACE in colorectal liver metastases](http://interventionalnews.com/wp-content/uploads/sites/13/2025/03/national-cancer-institute-SP2C8o2EZBw-unsplash-scaled.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://interventionalnews.com/cirel-study-finds-comparable-overall-survival-between-indication-for-irinotecan-tace-in-colorectal-liver-metastases/*

## L’essentiel

Results from CIREL—the largest, pan-European, prospective study of irinotecan-eluting transarterial chemoembolization (TACE) for colorectal liver metastases (CRLMs), show a comparably long median overall survival (OS) when used as salvage therapy and “promising” hepatic progression-free survival (HPFS) when used with systemic therapy or thermal ablation as a post-inductive or consolidation therapy. The study, published in European [&#8230;] The post CIREL study finds comparable overall survival between indication for irinotecan-TACE in colorectal liver metastases appeared first on Interventional News .

## Lien source

https://interventionalnews.com/cirel-study-finds-comparable-overall-survival-between-indication-for-irinotecan-tace-in-colorectal-liver-metastases/
